TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

92 hedge funds and large institutions have $900M invested in Theravance Biopharma in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 25 reducing their positions, and 16 closing their positions.

Holders
92
Holders Change
-6
Holders Change %
-6.12%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
37
Reduced
25
Closed
16
Calls
$1.84M
Puts
$789K
Net Calls
+$1.05M
Net Calls Change
+$16.1M

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$3.9M
2
3C
2
361 Capital
Colorado
$2.52M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$78.1M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$163M
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$7.43M

Top Sellers

1
WIM
1
Woodford Investment Management
United Kingdom
$221M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$10.2M
3
Parallax Volatility Advisers
3
Parallax Volatility Advisers
California
$0
4
JG
4
Jefferies Group
New York
$0
5
State of New Jersey Common Pension Fund D
5
State of New Jersey Common Pension Fund D
New Jersey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Citadel Advisors
101
Citadel Advisors
Florida
– -$284K -17,403 Closed
Wolverine Trading
102
Wolverine Trading
Illinois
– -$203K -12,409 Closed
AAMU
103
Amundi Asset Management US
Massachusetts
– -$75K -4,600 Closed
PCM
104
Prelude Capital Management
New York
– -$6K -392 Closed
PCP
105
Proficio Capital Partners
Massachusetts
– -$1K -54 Closed
1 2 3 4
5